购物车
您的购物车当前为空
Alacizumab is a human monoclonal antibody targeting KDR (VEGFR2). Alacizumab can be used for angiogenesis and oncology research, particularly studies involving VEGF/VEGFR signaling pathways.
别名 阿拉赛珠单抗
Alacizumab is a human monoclonal antibody targeting KDR (VEGFR2). Alacizumab can be used for angiogenesis and oncology research, particularly studies involving VEGF/VEGFR signaling pathways.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,790 | 待询 | |
| 5 mg | ¥ 10,800 | 待询 | |
| 10 mg | ¥ 17,700 | 待询 |
| 产品描述 | Alacizumab is a human monoclonal antibody targeting KDR (VEGFR2). Alacizumab can be used for angiogenesis and oncology research, particularly studies involving VEGF/VEGFR signaling pathways. |
| 别名 | 阿拉赛珠单抗 |
| 反应种属 | Human |
| 应用 | ELISA FCM Functional assay |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | Human IgG1 kappa |
| 推荐同型对照 |
| 偶联 | Unconjugated |
| 基因ID | |
| Uniprot ID | |
| 靶点 | KDR/FLK1/VEGFR2/CD309 |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多